SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046575
Filing Date
2023-12-29
Accepted
2023-12-29 16:05:34
Documents
13
Period of Report
2023-12-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45806
2 ex10-1.htm EX-10.1 227396
  Complete submission text file 0001493152-23-046575.txt   485875

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE orgs-20231222.xsd EX-101.SCH 3018
4 XBRL LABEL FILE orgs-20231222_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE orgs-20231222_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3183
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 231527677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)